Health
FDA Proposes New Ultra-Rare Disease Pathway
FDA proposes a new ultra-rare disease pathway for treatment approval on May 4, 2026, aiming to streamline access for pat…
Sarah Chen·
3 articles
FDA proposes a new ultra-rare disease pathway for treatment approval on May 4, 2026, aiming to streamline access for pat…
A new targeted therapy shows promise against aggressive childhood and adult cancers, marking a significant step forward…
An MP researcher has developed a groundbreaking smart drug delivery system that targets breast cancer cells without chem…